CCLA Investment Management Purchases 18,963 Shares of Synopsys, Inc. $SNPS

CCLA Investment Management boosted its position in Synopsys, Inc. (NASDAQ:SNPS) by 6.6% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 307,967 shares of the semiconductor company’s stock after acquiring an additional 18,963 shares during the quarter. Synopsys accounts for 0.1% of CCLA Investment Management’s holdings, making the stock its 12th largest holding. CCLA Investment Management’s holdings in Synopsys were worth $157,870,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Independence Bank of Kentucky grew its stake in shares of Synopsys by 120.0% during the second quarter. Independence Bank of Kentucky now owns 55 shares of the semiconductor company’s stock worth $28,000 after buying an additional 30 shares during the last quarter. Cornerstone Planning Group LLC grew its stake in shares of Synopsys by 275.0% during the first quarter. Cornerstone Planning Group LLC now owns 60 shares of the semiconductor company’s stock worth $25,000 after buying an additional 44 shares during the last quarter. Saudi Central Bank bought a new stake in shares of Synopsys during the first quarter worth $26,000. Princeton Global Asset Management LLC grew its stake in shares of Synopsys by 481.8% during the second quarter. Princeton Global Asset Management LLC now owns 64 shares of the semiconductor company’s stock worth $33,000 after buying an additional 53 shares during the last quarter. Finally, Clal Insurance Enterprises Holdings Ltd grew its stake in shares of Synopsys by 441.7% during the first quarter. Clal Insurance Enterprises Holdings Ltd now owns 65 shares of the semiconductor company’s stock worth $28,000 after buying an additional 53 shares during the last quarter. Institutional investors own 85.47% of the company’s stock.

Wall Street Analyst Weigh In

A number of analysts have weighed in on the stock. Needham & Company LLC decreased their target price on shares of Synopsys from $660.00 to $550.00 and set a “buy” rating on the stock in a research note on Wednesday, September 10th. KeyCorp decreased their target price on shares of Synopsys from $660.00 to $590.00 and set an “overweight” rating on the stock in a research note on Wednesday, September 10th. Baird R W cut shares of Synopsys from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, September 10th. Mizuho decreased their target price on shares of Synopsys from $700.00 to $600.00 and set an “outperform” rating on the stock in a research note on Thursday, September 11th. Finally, Morgan Stanley reduced their price objective on shares of Synopsys from $715.00 to $510.00 and set an “overweight” rating on the stock in a research note on Thursday, September 11th. Ten investment analysts have rated the stock with a Buy rating, five have assigned a Hold rating and four have given a Sell rating to the company. According to MarketBeat, Synopsys presently has an average rating of “Hold” and a consensus price target of $569.67.

Synopsys Stock Performance

Shares of Synopsys stock opened at $464.18 on Monday. The company has a quick ratio of 1.51, a current ratio of 1.62 and a debt-to-equity ratio of 0.52. Synopsys, Inc. has a twelve month low of $365.74 and a twelve month high of $651.73. The stock has a market cap of $86.22 billion, a price-to-earnings ratio of 36.43, a P/E/G ratio of 5.11 and a beta of 1.10. The company’s fifty day moving average is $509.56 and its 200 day moving average is $513.66.

Synopsys (NASDAQ:SNPS) last issued its quarterly earnings data on Tuesday, September 9th. The semiconductor company reported $2.30 earnings per share for the quarter, missing the consensus estimate of $3.75 by ($1.45). Synopsys had a return on equity of 10.82% and a net margin of 31.04%.The business had revenue of $1.74 billion during the quarter, compared to the consensus estimate of $1.77 billion. During the same period in the prior year, the firm earned $3.43 EPS. The business’s revenue for the quarter was up 14.0% compared to the same quarter last year. Synopsys has set its FY 2025 guidance at 12.760-12.800 EPS. Q4 2025 guidance at 2.760-2.80 EPS. Sell-side analysts forecast that Synopsys, Inc. will post 10.64 EPS for the current year.

Insider Activity

In related news, CAO Sudhindra Kankanwadi sold 9,873 shares of the business’s stock in a transaction on Monday, September 22nd. The shares were sold at an average price of $500.90, for a total value of $4,945,385.70. Following the transaction, the chief accounting officer owned 20,520 shares in the company, valued at $10,278,468. The trade was a 32.48% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Sassine Ghazi sold 11,366 shares of the business’s stock in a transaction on Tuesday, September 2nd. The shares were sold at an average price of $589.01, for a total transaction of $6,694,687.66. Following the completion of the transaction, the chief executive officer owned 71,615 shares in the company, valued at approximately $42,181,951.15. The trade was a 13.70% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 30,894 shares of company stock worth $16,760,783 in the last three months. Corporate insiders own 0.62% of the company’s stock.

Synopsys Profile

Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.